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Background: Mouse models are commonly used to study central nervous system disorders, in which cerebrospinal
fluid (CSF) drainage may be disturbed. However, mouse CSF drainage into lymphatics has not been thoroughly
characterized. We aimed to image this using an in vivo approach that combined quantum dot fluorescent
nanoparticles with hyperspectral imaging.
Findings: Quantum dot 655 was injected into the CSF of the cisterna magna in seven mice and visualized by
in vivo hyperspectral imaging at time points 20 and 40 min, 1, 2, and 6 h after injection. In controls (n = 4), quantum
dots were applied directly onto intact dura mater covering the cisterna magna. After imaging, lymph nodes in the
neck were harvested and processed post-mortem for histological analysis. After injection into the CSF, quantum dot
signal was detected in vivo in submandibular lymph nodes of all mice studied as early as 20 min, but not in controls.
Post-mortem gross and histological examination of lymph nodes confirmed in vivo observations.
Conclusions: Non-invasive in vivo hyperspectral imaging is a useful tool to study CSF lymphatic drainage and is
relevant to understanding this pathway in CNS disease models.
Keywords: Cerebrospinal fluid, Lymphatic, Nanotechnology, In vivo imaging, Mouse, Hyperspectral imaging,
Non-invasive imaging, Quantum dotFindings
Introduction
Cerebrospinal fluid (CSF) bathes the central nervous
system (CNS) and plays roles in a number of important
functions, including hydraulic cushioning, nutrient
delivery, drainage of waste, and immune surveillance
[1]. Altered CSF circulation, mainly due to blockage
of CSF outflow, is implicated in hydrocephalus and
increased intracranial pressure (ICP) associated with
ischemic or hemorrhagic cerebrovascular disease [2].
Tracer studies have shown that CSF drains via arachnoid
granulations into the bloodstream and along olfactory
nerves into nasal lymphatics [3,4]. Studies of CSF drainage
have been performed in cat, rabbit, and sheep due to
their relatively large lymphatic vessels that facilitate
cannulation and collection experiments [5,6]. Non-invasive* Correspondence: yucely@smh.ca
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stated.imaging modalities such as scintigraphy [7] and computed
tomographic scanning [8] have been used to visualize
lymphatic drainage of CSF in animals such as cats and
rabbits, avoiding the need for surgical exposure of the
lymphatic pathway for cannulation or visualization.
However, the low optical resolution of such methods
has precluded their use to study CSF drainage pathways
in mice. Although monitoring drainage of dyes injected
into the CSF by direct visualization of surgically exposed
cervical lymph nodes has been described [9], the lack of
non-invasive in vivo methods to assess lymphatic drainage
of CSF has hampered our understanding of this pathway
in mouse, an important laboratory species for studies
of CNS disorders. Optical hyperspectral imaging is a
non-invasive, whole animal imaging technique based
on the spectral analysis of light reflected by the tissue
components. Spectral “unmixing” allows the separation
of the tracer signal from the autofluorescence of skin
and other tissues. Non-invasive techniques combining
hyperspectral imaging with quantum dots (QD) have
recently been used to assess lymphatic drainage from the
skin [10]. We have used a similar technique to studyl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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gate the lymphatic drainage of CSF in mice using QD
fluorescent nanoparticles injected into the cisterna magna
and visualized by hyperspectral imaging in vivo.
Materials and methods
Using a protocol approved by the institutional Animal
Care Committee, male 129SVE mice (age 6–10 weeks;
n = 11) were shaved (head and neck) and mounted
under general anesthesia (1.5% isoflurane inhalation in
O2) onto a stereotaxic frame (Kopf Instruments, CA,
USA) in a prone position and a 1 cm skin incision was
made from the base of the neck to the tip of the occiput.
Muscles of the neck were bluntly dissected with forceps to
expose the dura mater covering the cisterna magna and
the incision was held open with retractors. Quantum dot
655 (Qdot® ITKTM Carboxyl Quantum Dots, Invitrogen,
OR, USA), fluorescent nanoparticles with a hydrodynamic
size of 19 nm, ellipsoid shape, CdSe/ZnS core/shell, and
an emission peak at 655 nm, were used as formulated by
the manufacturer (8 μM QD in a 50 mM borate buffer).
Negatively-charged QDs were chosen because a negative
surface charge has been shown to improve lymphatic
uptake and retention [13]. In seven mice, using a 25 μL
syringe (Hamilton Co., NV, USA) with 33 g needle (20°
beveled point, Hamilton Co., NV, USA) mounted on a
stereotaxic arm, 3 μL of QD solution was manually
injected over 1 min into the CSF of the cisterna magna.
Any leaked CSF (approx. 1–2 μL) was absorbed with
micro-sponges and the injection site was immediately
sealed with cyanoacrylate tissue glue (Vetbond, 3M
Inc., MN, USA) to prevent further leakage. Experiments
were performed in four additional mice to control for
possible drainage of leaked tracer along lymphatics in
the posterior cervical tissues. For these control mice,
3 μL of QD was applied onto the intact dura mater
surface overlying the cisterna magna. For all mice the
skin incision was closed and subcutaneous analgesia with
buprenorphine (Temgesic, 0.3 mg/mL, Reckitt Benckiser,
Berkshire, UK) 0.1 mg/kg plus 1.0 mL saline for rehydration
were given. After the injection, mice were removed
from the stereotaxic frame and returned to cages prior
to imaging.
In four additional mice, ICP was continuously measured
under anesthesia (same as above) before, during, and
10 min after injection of 3 μL of QD into CSF of the
cisterna magna, followed by immediate sacrifice by
CO2 inhalation. A blunt tip needle was connected to a
pressure probe and monitoring device (mo. MPM-1,
Integra, NJ, USA) through a saline-filled tube and placed
above the dura mater in a 1 mm burr hole in the parietal
bone and sealed with bone wax. ICP measurements before
and after tracer injection were compared using a paired
t-test and no significant change was noted whencomparing pre-injection to 10 min post-injection ICP,
respectively (7.3 ± 0.96 mmHg [Mean ± S.D.] vs. 8.6 ±
1.1 mmHg; n = 4, p = 0.11).
To detect drainage into cervical lymph nodes in vivo,
mice were imaged under isoflurane anesthesia in the
supine position using the protocol described in Tam
et al. 2011 [11]. Anesthesia was discontinued between
imaging sessions, and mice were returned to cages. In
vivo hyperspectral imaging was performed (MaestroTM,
CRi, MA, USA) 20 and 40 min, 1, 2 and 6 hours after tracer
injection, and mice were sacrificed by CO2 inhalation
following the final imaging session. Hyperspectral images
were analyzed using Maestro 2.4 imaging software
unmixing algorithms to visualize QD signal, with creation
of a spectral library from emission spectra of QD, tissue
autofluorescence, and food autofluorescence.
To confirm the presence and further localize QD in
neck tissues, hyperspectral imaging of post-mortem
experimental and control mice was performed. After
imaging in vivo, animals were immersion fixed in 4%
paraformaldehyde and cryoprotected in glycerol solution
using the protocol from Tam et al. 2011 [11]. The head,
neck, and upper torso were scanned with skin removed to
expose the submandibular salivary glands and associated
lymph nodes. All neck tissue with QD signal was
harvested and the remainder of the mouse, along
with the dissected tissue block, was rescanned. If
rescanning revealed signal in the deep neck tissue,
the remainder of the neck was harvested. Neck tissue
blocks were embedded in cryomatrix and frozen with
solid CO2 (dry ice). Frozen tissue blocks were serially
sectioned (140 μm thick) using a sliding microtome
(Leica SM2400, Leica, Germany). Sections were collected
on strips of plastic wrap and mounted on charged
slides using PVA-DABCO anti-fade mounting medium
(polyvinyl alcohol, Sigma-Aldrich, MO, USA; DABCO,
MP Biomedicals, CA, USA). All sections were scanned
hyperspectrally with reduced exposure time of 300 ms
to screen for regions with QD signal.
To validate in vivo detection of QD within lymph
nodes, immunofluorescence staining for collagen-IV and
nuclear counterstaining was performed on neck sections
with QD signal using the staining protocol from Tam
et al. 2013 [12]. Neck sections were analyzed by confocal
laser-scanning microscope (TCS SL, Leica, Germany).
Identification of lymph nodes was undertaken using
the nomenclature proposed by Van den Broeck and
coworkers [14], with the exception that we have used
the commonly accepted term of “submandibular lymph
nodes” instead of “mandibular lymph nodes”.
Results
With in vivo hyperspectral imaging, QD signal was evident
in the submandibular region of the right and left sides of
Figure 1 In vivo hyperspectral fluorescence images after injection of QD into CSF. Ventral view of head and neck 20 min (a), 40 min (b),
1 h (c), 2 h (d) and 6 h (e) following injection of QD into CSF of cisterna magna. QD signal (red) is seen in the submandibular region of the right
and left side of the neck. Skin/fur autofluoresence (green), autofluorescence from food (blue). (f) Spectral emission profile (grey dotted line) of the
region indicated by the arrow in (e) shows that the signal matches the profile for QD (red line) and is distinct from that for skin/fur
autofluorescence (green line) and that of autofluorescence from food (blue line). Scale = 1 cm.
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40 min. QD signal remained in the same regions at 1, 2
and 6 h after tracer injection, with peak intensity seen
at 1–2 h and a slight decrease by 6 h (Figure 1a-e). The
signal was confirmed to match the emission profile of
QD by spectral analysis through unmixing algorithms
(Figure 1f ). QD signal was not detected in vivo in the
neck region of control mice by 6 h after QD was applied
to dura mater covering the cisterna magna (Figure 2a).
Spectral analysis of the submandibular region in these
mice showed an emission profile matching tissue auto-
fluorescence (Figure 2b).Figure 2 In vivo hyperspectral fluorescence image of control mouse.
the dura mater covering the cisterna magna. No QD signal (red) is visible. S
(b) Spectral emission profile (grey dotted line) of the region indicated
matched the profile for skin/fur autofluorescence (green line) and is di
food (blue line). Scale = 1 cm.Post-mortem imaging revealed QD in the region of
submandibular lymph nodes in all mice 6 hours after
CSF injection (Figure 3a,b). After removal of the salivary
glands and associated lymph nodes, rescanning of mice
revealed focal points of QD signal in the region of the
deep cervical lymph nodes in 2 of 7 mice with CSF
injections, although drainage to these nodes was not
apparent in vivo. In control mice with extra-dural QD
application, signal was detected post-mortem in the
superficial parotid lymph nodes (n = 3/4; Figure 3c) and
deep cervical lymph nodes (n = 3/4), but not in sub-
mandibular lymph nodes.(a) Ventral view of the head and neck 6 h after QD application onto
kin/fur autofluoresence (green), autofluorescence from food (blue).
by the arrow in (a) shows that signal in the submandibular region
stinct from QD signal (red line) and that of autofluorescence from
a b c
Figure 3 Post-mortem hyperspectral fluorescence imaging with skin removed. (a) Diagram of murine lymph nodes in the neck showing
locations for the submandibular (SM; blue), superficial parotid (SP; green), and deep cervical (DC; yellow) lymph nodes. (b) Ventral view of the
upper body and head showing intense QD signal (red) in left and right submandibular region 6 h after QD injection into CSF. (c) Right latero-ventral
view of the head and neck of a control mouse showing weak QD signal (red) in the right superficial parotid lymph node 6 h after QD application onto
the dura mater overlying the cisterna magna. Tissue autofluorescence is shown in green. Scale = 1 cm.
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collagen-IV showed QD signal within all submandibular
lymph nodes beneath the collagen-IV-positive capsule
6 hours after CSF injection (Figure 4). Hematoxylin and
eosin staining of the adjacent sections confirmed the
presence of lymph node cytoarchitecture. QD signal in
the superficial parotid and deep cervical lymph nodes of
control mice was confirmed with histological analysis of
neck sections.
Discussion
Results from this study are in keeping with those from
non-invasive imaging of CSF drainage to lymph nodes of
the neck in larger species [7,8]. In rabbit [7,8] and cat
[8], tracer injected into CSF of the lateral ventricle was
non-invasively imaged draining to the cervical lymph
nodes, however these studies did not specify the subset
of cervical lymph nodes.
Compared to previous non-invasive approaches [8], a
higher degree of sensitivity, with earlier signal detection
was possible using our combined quantum dot and
hyperspectral imaging approach. Although drainage ofa
Figure 4 QD in submandibular lymph nodes 6 hours after injection in
subcapsular sinus of a 140 μm thick section. The region delineated by the box
has been stained for collagen-IV (blue) and lymph node architecture is elucidatCSF to surgically exposed lymph nodes can be visualized
as early as 2 min after tracer injection in mice [9], this is
the first non-invasive imaging study to detect drainage as
early as 20 min and at multiple time points after injection
using the same animals.
In all 7 mice studied, CSF drained preferentially to the
submandibular lymph nodes, though drainage to deep
cervical lymph nodes was also noted in 2 mice. One
study in rat showed India ink injected into CSF was
found solely in deep cervical and lumbar lymph nodes
[3], while another showed human serum albumin injected
into CSF elicited an immune response in both deep and
superficial cervical nodes [15]. In sheep, radioactive
albumin drained preferentially to retropharyngeal and
deep cervical lymph nodes [6]. It has been shown that
lymphatics of the head and neck can drain either directly
to deep cervical nodes, or indirectly via superficial nodes,
such as the submandibular nodes [16]. The preferential
location of QD in the submandibular lymph nodes may
depend on tracer characteristics, anatomical differences
between species, or imaging time points, and does not
exclude the presence of alternate lymphatic drainageb
to CSF. Confocal microscope images showing QD (red) within the
in (a) can be seen in (b) at higher power. The capsule of the lymph node
ed with Sytox green nuclear stain (green). Scale = 300 μm (a), 150 μm (b).
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charge of tracers and multiple time points may be helpful
to map the regional lymphatic drainage pathway(s).
Signal was not detected in vivo in the submandibular
region of control mice, indicating that tracer leakage at
the injection site was not responsible for signal observed
in the submandibular region following CSF injection.
There are some potential shortcomings for these
experiments. The tonicity of the injected QD solution
prepared by the manufacturer did not match the tonicity
of CSF and possible effects of this are unknown. The use
of QDs with heavy metal core composition for in vivo
studies has also been questioned due to the potential for
toxicity. However, it has been demonstrated in animals
that there is no appreciable toxicity even after breakdown
of QDs in vivo [17]. Furthermore, the presence of signal
in tissues below the threshold of detection for this
imaging system cannot be excluded. Lastly, since this was
a qualitative study, additional work should be undertaken
to optimize this technique for quantitative imaging [18].
The CSF and brain interstitial fluid are highly inter-
connected, and lymphatic drainage plays an important
immunological role here [19]. Non-invasive in vivo
imaging techniques as described in this study may also
be relevant to investigation of interstitial fluid outflow
and CNS immunology.
Conclusions
The combined use of QD nanoparticles and hyperspectral
imaging may be suitable for longer-term studies due to its
relatively non-invasive nature, and capacity for multiple
longitudinal imaging sessions in the same mouse. It may
present an advantage over more invasive methods that
require prolonged deep anesthesia and immobilization
that are known to slow lymphatic flow [20]. This in vivo
approach to image lymphatic drainage provides a unique
opportunity to further assess lymphatic drainage of CSF in
mouse models of CNS disorders.
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